Social media addiction associated with poorer mental well-being
THURSDAY, May 23, 2024 (HealthDay News) — One in six girls in high school has possible social media addiction, which is tied to poorer mental well-being, according to a study published online May 21 in the Archives of Disease in Childhood.
Silja Kosola, M.D., Ph.D., from the University of Helsinki, and colleagues measured smartphone and social media use objectively to evaluate its associations with mental health and well-being. The analysis included 1,164 first-year female students from 21 socioeconomically diverse high schools.
The researchers found that based on the Bergen Social Media Addiction Scale (BSMAS), 183 adolescents (16.6 percent) had possible social media addiction. BSMAS scores were significantly associated with higher anxiety (r = 0.380), poorer body image (r = −0.268), poorer health (r= −0.252), lower mood (r = −0.261), greater tiredness (r = 0.347), and greater loneliness (r = 0.226). Based on the 564 adolescents who sent screenshots of their smartphone use, average daily use was 5.8 hours, including 3.9 hours of social media. BSMAS and well-being measures were similar for participants who sent screenshots and those who did not.
“While some advocate for increased mental health services to tackle the rise in adolescent anxiety, no services will suffice unless the root causes are addressed,” the authors write. “Policymakers should strengthen safety standards and urge technology companies to prioritize safety and health in the development of social media.”
Maternal Night-Shift Work Tied to Later Neurodevelopmental Issues in Offspring
Financial Incentives Boost Tobacco Abstinence in Underserved Adults
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing
More Than 1 in 4 Americans Misrepresent Symptoms to Get Antibiotics
Hospital Outcomes Better When Patients Treated by Female Physicians
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers